Infrared Neural Stimulation (INS)NCT04601337
Clinical Safety and Efficacy of Infrared Neural Stimulation During Nerve Transfers
An observational study of Infrared Neural Stimulation (INS), run by Vanderbilt University Medical Center at 1 site in United States.
Trial summary
Many surgical procedures such as brachial plexus reconstruction, nerve repair, and dorsal root rhizotomies rely on the spatial selectivity of their neural stimulation methods to identify specific nerve fascicles or rootlets. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Infrared Neural Stimulation (INS)
- What is being tested?
- Infrared Neural Stimulation
- Type of treatment
- Surgery or procedure
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Mar 2025to 19 Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients will be identified through VUMC Orthopaedic outpatient clinics and consultations.
Who may be able to join
- Patient set to undergo a brachial plexus reconstruction or nerve transfer surgery
- 18 years or older
Who cannot join
- Patients under the age of 18
- Patients who are unwilling to take part in study
- Patients who have documented psychiatric disorder that limits ability to consent
- Patients who do not speak English
- Patients who are pregnant
Trial locations and contacts
1 site in 1 country.
United States1 site
Vanderbilt Department of Orthopaedic Surgery
Nashville, Tennessee, 37232-8828
About this study
Many surgical procedures such as brachial plexus reconstruction, nerve repair, and dorsal root rhizotomies rely on the spatial selectivity of their neural stimulation methods to identify specific nerve fascicles or rootlets. Due to the variable distribution of nerves between patients, many times it is not enough to rely on the historical topography of nerves to determine their location and identity.Currently, electrical stimulation (ES) methods are used to stimulate nerves in order to locate and map them intraoperatively. ES, however, is subject to current spread in which the electrical stimulus extends beyond the area proximal to the electrode into the surrounding tissue. This can result in the stimulation of multiple fascicles introducing ambiguity as to the location and/or identity of a specific nerve or fascicle. Our group has shown that infrared neural stimulation (INS), a novel optical and label-free means of exciting neural tissue, is capable of safely stimulating nerves with a higher degree of spatial specificity than traditional ES methods. Our clinical studies have even shown that INS can outperform ES, achieving isolated rootlet responses. The investigators hypothesize that the spatial selectivity of INS can be further utilized in upper extremity surgeries such as brachial plexus reconstruction and nerve transfers to improve intraoperative nerve identification and localization. While the initial clinical work was performed with a costly clinical laser system, our group has demonstrated the efficacy of cost-effective laser diode systems for INS in animal models in vivo.The safety of these lasers, however, has yet to be proven histologically in human patients. The objective of this proposal is two-fold: to demonstrate the efficacy of INS for spatially selective nerve stimulation in the upper extremity and to determine the histological safety of INS using diode laser systems in human patients. To do so, the investigators will recruit patients undergoing brachial plexus reconstruction (BPR) and nerve transfer surgeries wherein both the effectiveness and spatial selectivity of INS can be demonstrated and histological samples can be obtained without detriment to the patients' quality of care or recovery. To accomplish these objectives, the investigators propose the following aims:
Aim 1: Design and fabricate a clinical fiberoptic probe for a diode-based INS system Aim 2: Demonstrate the efficacy of INS in nerve transfer cases Aim 3: Determine the histological safety of the diode-based INS system
Read the detailed description
A broad range of surgical procedures involve locating and identifying nerves and neural structures. In cases like brachial plexus reconstruction, the surgeon needs to identify specific nerve fascicles for grafting. While in other cases like dorsal root rhizotomies, the surgeon needs to identify hyperactive nerve rootlets for transection. The ability to accurately identify and localize nerves is critical in avoiding unintentional and detrimental consequences which can be costly source of medicolegal litigation. Surgeons commonly depend on their anatomical knowledge and visualization of the surgical field to identify and locate nerves. The distribution of nerves, however, varies from person to person often deviating from anatomical atlases. To account for this interpatient variability, surgeons also utilize electrical stimulation (ES) methods to identify and locate nerves and nerve fascicles intraoperatively. After ES, surgeons rely on electromyography or the presence of visible muscle contractions to confirm the identity and location of the stimulated nerve. ES, however, is constrained by inherent physical limitations. Current spread, in which electrical current disperses into the surrounding tissue, has long plagued ES methods. As a result of current spread, the electrical stimulus will extend beyond the point of contact with the stimulation probe activating adjacent nerve fascicles. Consequently, ES' poor stimulation focality makes it a non-ideal means to target small neural targets or to precisely monitor neural structures in immediate contact with the stimulation electrode. In clinical procedures, the activation of distant neural tissue or multiple neural structures can introduce ambiguity and uncertainty as to identity and location of specific neural structures that causes concern among surgeons. Thus, there is a need for a neural stimulation technique with a higher degree of spatial selectivity to improve nerve localization and identification during surgery.
Infrared neural stimulation (INS) is a label-free optical method used to excite neural tissue with low energy pulses of infrared light. As an optical neurostimulation technique, INS possesses a high degree of spatial specificity without the need for direct contact with the tissue (Figure 1). Our group has repeatedly demonstrated the spatial specificity of INS to activate individual nerve fascicles in rats, nonhuman primates, and humans in vivo. The initial findings from our group have also lead other groups to leverage the spatial selectivity of INS for other clinical applications such as nerve monitoring and cardiac pacing. The inherent spatial precision of INS is a direct result of its underlying biophysical mechanism. The deposition of infrared light into the neural tissue causes a transient thermal gradient that depolarizes the cell membrane through a thermally induced change in membrane capacitance. The thermal energy from the infrared pulses is spatially confined to the irradiated volume as determined by laser spot size and the penetration depth of the light into tissue. Our group as well as others have histologically proven that INS can safely and reliably excite nerves without inflicting damage. Given these advantages over traditional means of ES, the investigators believe INS is a viable alternative stimulation technique especially in surgical cases where there is a need for confined neurostimulation. The goal of this proposal is to take advantage of INS' intrinsic strengths and apply them to upper limb surgeries where spatially precise neurostimulation is necessary for nerve identification and localization. This study will build upon our group's previous clinical work and further establish INS as a valuable addition to clinical neurostimulation methods.
The objective of this proposal is two-fold: to demonstrate the efficacy of INS for spatially selective nerve stimulation in the upper extremity and to determine the histological safety of INS using diode laser systems in human patients. To do so, the investigators will recruit patients undergoing brachial plexus reconstruction (BPR) and nerve transfer surgeries wherein both the effectiveness and spatial selectivity of INS can be demonstrated and histological samples can be obtained without detriment to the patients' quality of care or recovery. To accomplish these objectives, the investigators propose the following aims:
Aim 1: Design and fabricate a clinical fiberoptic probe for a diode-based INS system Using our existing diode lasers, the investigators will create a clinical diode laser INS system by constructing INS fiberoptic probes. Fiberoptic probes will be designed and characterized to collect light from our diode lasers and deliver that light to the nerve. The probes will be sterilizable, ergonomic and maneuverable, transmissive at the relevant wavelengths, and provide consistent stimulation parameters. The probe design will be based on existing clinical ES probes and modified based on surgeon feedback.
Aim 2: Demonstrate the efficacy of INS in nerve transfer cases While INS with expensive clinical lasers has been shown to be an effective means of nerve stimulation, INS with diode lasers has yet to be demonstrated in human patients. Here, the investigator will stimulate nerves identified for transfer or grafting over a range of simulation parameters (pulse width, spot size, energy per unit area, etc) to determine the stimulation threshold. Only portions of the nerve that are no longer functionally required will be stimulated optically. Successful INS events will be determined by visual muscle contractions. Stimulation thresholds will be determined by fitting the data to a cumulative distribution function.
Aim 3: Determine the histological safety of the diode-based INS system In conjunction with Aim 2, stimulation sites on the nerve will be harvested and histologically examined for evidence of INS-induced damage. Stimulation sites will be marked with a tissue dye and excised for histological preparation. Regarding the tissue dye, the study surgeon will use a sterile surgical marking pen to mark the stimulation site. These sterile surgical marking pens are meant to be used in-vivo to mark tissue. The sterile surgical marking pens are used regularly in routine care to mark tissue intraoperatively. There is no additional risk to study participants who will have their stimulation site marked with a sterile surgical marking pen. The stimulation site (nerve segment) that will be marked with the sterile surgical marking pen will be excised for histological preparation.
Once the samples are fixed and sliced, they will be stained with toluidine blue and/or Luxol fast blue-Periodic acid Schiff stains and imaged. Imaged slides will be examined for evidence of myelin disruption, collagen hyalinization, and charring among other criteria. A histological damage grading scheme will also be developed based on the severity and depth of the damage with respect to the nerve itself. Damage thresholds will similarly be determined using Probit Analysis and compared to the stimulation threshold to determine the margin of safety.
INS has the potential to serve as valuable neural stimulation technique in the clinic. Due to its high degree of spatial selectivity, INS could improve upon current electrical methods of stimulation that can excite multiple nerves or fascicles at once due to current spread and therefore reduce uncertainty during nerve identification procedures. While INS has been successfully and safely utilized in humans, cost-effective laser diode systems have yet to be evaluated. This proposal will allow for the development and testing of a clinical diode-based INS system in terms of both efficacy and safety. This proposal brings together a complementary team of investigators with unique expertise in both the clinical and technical aspects of INS and its applications. The utilization of INS in BPR and nerve transfer cases will allow us to determine the stimulation and safety thresholds of diode-based INS in humans will pave the way for this technique to be employed in other procedures where improved spatial specificity is highly advantageous. By extending the use of INS to upper limb cases, this technique could significantly impact the standard of care in surgeries utilizing stimulation to identify specific nerves and nerve fascicles.
- Conditions
- Infrared Neural Stimulation (INS)
- Being tested
- Infrared Neural Stimulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Infrared Neural StimulationProcedure or surgery
We will stimulate nerves identified for transfer or grafting over a range of simulation parameters (pulse width, spot size, energy per unit area, etc) to determine the stimulation threshold. Only portions of the nerve that are no longer functionally required will be stimulated optically. Successful INS events will be determined by visual muscle contractions. Stimulation thresholds will be determined by fitting the data to a cumulative distribution function. Stimulation sites on the nerve will be harvested and histologically examined for evidence of INS-induced damage.
| Study group | Role | What they receive |
|---|---|---|
| Brachial plexus and/or nerve transfer surgery patients | Patients set to undergo brachial plexus reconstruction or nerve transfer surgery that are 18 years or older. Receives: Procedure: Infrared Neural Stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stimulation threshold
The stimulation threshold (H100) will be defined as the radiant exposure at which 100% of the laser pulses evoked CMAP responses and will be used to compare all data. To determine the stimulation threshold, recordings from each trial will be analyzed to determine the number of INS-evoked CMAPs. The number of evoked CMAPs will be divided by the total number of delivered pulses to determine the activation probability for every radiant exposure.
Measured: Day of surgery
Transition rate
The transition rate to 100% activation probability will be defined as the peak slope of the fitted CDF (mpeak). This represents how well-defined the stimulation threshold is. For instance, a more immediate transition from 0 to 100%, a greater mpeak, corresponds to every pulse going from 0% to 100% activation over a small range of radiant exposures. Practically, a sharper transition rate translates to more reliable and predictable stimulation. Changes in peak CDF slope will then be compared across conditional groups.
Measured: Day of surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2020
- Study start1 Mar 2025
- Primary completion19 Mar 2025
- Study completion19 Mar 2025
Why it stopped: Recruitment never started.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (33)Papers the sponsor has linked to this study.
- Other trials for Infrared Neural Stimulation (INS)Studies of the same condition, open and under way.
- More trials run by Vanderbilt University Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Vanderbilt University Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mihir Desai, Vanderbilt University Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04601337
- Sponsor's protocol ID
- 200868
- Status last verified
- Mar 2025
- First submitted
- 12 Oct 2020
- Last updated
- 1 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to make individual participant data available to other researchers.
Publications
Antoniadis G, Kretschmer T, Pedro MT, Konig RW, Heinen CP, Richter HP. Iatrogenic nerve injuries: prevalence, diagnosis and treatment. Dtsch Arztebl Int. 2014 Apr 18;111(16):273-9. doi: 10.3238/arztebl.2014.0273.
PubMed 24791754Teboul F, Kakkar R, Ameur N, Beaulieu JY, Oberlin C. Transfer of fascicles from the ulnar nerve to the nerve to the biceps in the treatment of upper brachial plexus palsy. J Bone Joint Surg Am. 2004 Jul;86(7):1485-90. doi: 10.2106/00004623-200407000-00018.
PubMed 15252097Oberlin C, Beal D, Leechavengvongs S, Salon A, Dauge MC, Sarcy JJ. Nerve transfer to biceps muscle using a part of ulnar nerve for C5-C6 avulsion of the brachial plexus: anatomical study and report of four cases. J Hand Surg Am. 1994 Mar;19(2):232-7. doi: 10.1016/0363-5023(94)90011-6.
PubMed 8201186Leechavengvongs S, Witoonchart K, Uerpairojkit C, Thuvasethakul P, Ketmalasiri W. Nerve transfer to biceps muscle using a part of the ulnar nerve in brachial plexus injury (upper arm type): a report of 32 cases. J Hand Surg Am. 1998 Jul;23(4):711-6. doi: 10.1016/S0363-5023(98)80059-2.
PubMed 9708387Popovic D, Gordon T, Rafuse VF, Prochazka A. Properties of implanted electrodes for functional electrical stimulation. Ann Biomed Eng. 1991;19(3):303-16. doi: 10.1007/BF02584305.
PubMed 1928872Liang DH, Lusted HS, White RL. The nerve-electrode interface of the cochlear implant: current spread. IEEE Trans Biomed Eng. 1999 Jan;46(1):35-43. doi: 10.1109/10.736751.
PubMed 9919824Testerman RL. Comments on "accuracy limitations of chronaxie values". IEEE Trans Biomed Eng. 2005 Apr;52(4):750. doi: 10.1109/tbme.2004.836506.
PubMed 15825879Wells J, Konrad P, Kao C, Jansen ED, Mahadevan-Jansen A. Pulsed laser versus electrical energy for peripheral nerve stimulation. J Neurosci Methods. 2007 Jul 30;163(2):326-37. doi: 10.1016/j.jneumeth.2007.03.016. Epub 2007 Mar 31.
PubMed 17537515Cayce JM, Wells JD, Malphrus JD, Kao C, Thomsen S, Tulipan NB, Konrad PE, Jansen ED, Mahadevan-Jansen A. Infrared neural stimulation of human spinal nerve roots in vivo. Neurophotonics. 2015 Jan;2(1):015007. doi: 10.1117/1.NPh.2.1.015007. Epub 2015 Feb 23.
PubMed 26157986Cayce JM, Friedman RM, Chen G, Jansen ED, Mahadevan-Jansen A, Roe AW. Infrared neural stimulation of primary visual cortex in non-human primates. Neuroimage. 2014 Jan 1;84:181-90. doi: 10.1016/j.neuroimage.2013.08.040. Epub 2013 Aug 28.
PubMed 23994125Morris LG, Ziff DJ, DeLacure MD. Malpractice litigation after surgical injury of the spinal accessory nerve: an evidence-based analysis. Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):102-7. doi: 10.1001/archotol.134.1.102.
PubMed 18209145Abadin SS, Kaplan EL, Angelos P. Malpractice litigation after thyroid surgery: the role of recurrent laryngeal nerve injuries, 1989-2009. Surgery. 2010 Oct;148(4):718-22; discussion 722-3. doi: 10.1016/j.surg.2010.07.019. Epub 2010 Aug 14.
PubMed 20709343Kern KA. Medicolegal analysis of errors in diagnosis and treatment of surgical endocrine disease. Surgery. 1993 Dec;114(6):1167-73; discussion 1173-4.
PubMed 8256224Klotz L, Heaton J, Jewett M, Chin J, Fleshner N, Goldenberg L, Gleave M. A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. J Urol. 2000 Nov;164(5):1573-8.
PubMed 11025707Walsh PC, Marschke P, Catalona WJ, Lepor H, Martin S, Myers RP, Steiner MS. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons. Urology. 2001 Mar;57(3):491-4. doi: 10.1016/s0090-4295(00)01067-0.
PubMed 11248626
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Safety and Efficacy of Infrared Neural Stimulation During Nerve Transfers
- ClinicalTrials.gov ID
- NCT04601337
- Acronym / sponsor ID
- 200868
- Conditions
- Infrared Neural Stimulation (INS)
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Recruitment never started.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Vanderbilt University Medical CenterUniversity, hospital or other
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 19 Mar 2025 (actual)
- Study completion
- 19 Mar 2025 (actual)
- First posted
- 23 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many surgical procedures such as brachial plexus reconstruction, nerve repair, and dorsal root rhizotomies rely on the spatial selectivity of their neural stimulation methods to identify specific nerve fascicles or rootlets. Due to the variable distribution of nerves between patients, many times it is not enough to rely on the historical topography of nerves to determine their location and identity.Currently, electrical stimulation (ES) methods are used to stimulate nerves in order to locate and map them intraoperatively. ES, however, is subject to current spread in which the electrical stimulus extends beyond the area proximal to the electrode into the surrounding tissue. This can result in the stimulation of multiple fascicles introducing ambiguity as to the location and/or identity of a specific nerve or fascicle. Our group has shown that infrared neural stimulation (INS), a novel optical and label-free means of exciting neural tissue, is capable of safely stimulating nerves with a higher degree of spatial specificity than traditional ES methods. Our clinical studies have even shown that INS can outperform ES, achieving isolated rootlet responses. The investigators hypothesize that the spatial selectivity of INS can be further utilized in upper extremity surgeries such as brachial plexus reconstruction and nerve transfers to improve intraoperative nerve identification and localization. While the initial clinical work was performed with a costly clinical laser system, our group has demonstrated the efficacy of cost-effective laser diode systems for INS in animal models in vivo.The safety of these lasers, however, has yet to be proven histologically in human patients. The objective of this proposal is two-fold: to demonstrate the efficacy of INS for spatially selective nerve stimulation in the upper extremity and to determine the histological safety of INS using diode laser systems in human patients. To do so, the investigators will recruit patients undergoing brachial plexus reconstruction (BPR) and nerve transfer surgeries wherein both the effectiveness and spatial selectivity of INS can be demonstrated and histological samples can be obtained without detriment to the patients' quality of care or recovery. To accomplish these objectives, the investigators propose the following aims:
Aim 1: Design and fabricate a clinical fiberoptic probe for a diode-based INS system Aim 2: Demonstrate the efficacy of INS in nerve transfer cases Aim 3: Determine the histological safety of the diode-based INS system
Detailed description
A broad range of surgical procedures involve locating and identifying nerves and neural structures. In cases like brachial plexus reconstruction, the surgeon needs to identify specific nerve fascicles for grafting. While in other cases like dorsal root rhizotomies, the surgeon needs to identify hyperactive nerve rootlets for transection. The ability to accurately identify and localize nerves is critical in avoiding unintentional and detrimental consequences which can be costly source of medicolegal litigation. Surgeons commonly depend on their anatomical knowledge and visualization of the surgical field to identify and locate nerves. The distribution of nerves, however, varies from person to person often deviating from anatomical atlases. To account for this interpatient variability, surgeons also utilize electrical stimulation (ES) methods to identify and locate nerves and nerve fascicles intraoperatively. After ES, surgeons rely on electromyography or the presence of visible muscle contractions to confirm the identity and location of the stimulated nerve. ES, however, is constrained by inherent physical limitations. Current spread, in which electrical current disperses into the surrounding tissue, has long plagued ES methods. As a result of current spread, the electrical stimulus will extend beyond the point of contact with the stimulation probe activating adjacent nerve fascicles. Consequently, ES' poor stimulation focality makes it a non-ideal means to target small neural targets or to precisely monitor neural structures in immediate contact with the stimulation electrode. In clinical procedures, the activation of distant neural tissue or multiple neural structures can introduce ambiguity and uncertainty as to identity and location of specific neural structures that causes concern among surgeons. Thus, there is a need for a neural stimulation technique with a higher degree of spatial selectivity to improve nerve localization and identification during surgery.
Infrared neural stimulation (INS) is a label-free optical method used to excite neural tissue with low energy pulses of infrared light. As an optical neurostimulation technique, INS possesses a high degree of spatial specificity without the need for direct contact with the tissue (Figure 1). Our group has repeatedly demonstrated the spatial specificity of INS to activate individual nerve fascicles in rats, nonhuman primates, and humans in vivo. The initial findings from our group have also lead other groups to leverage the spatial selectivity of INS for other clinical applications such as nerve monitoring and cardiac pacing. The inherent spatial precision of INS is a direct result of its underlying biophysical mechanism. The deposition of infrared light into the neural tissue causes a transient thermal gradient that depolarizes the cell membrane through a thermally induced change in membrane capacitance. The thermal energy from the infrared pulses is spatially confined to the irradiated volume as determined by laser spot size and the penetration depth of the light into tissue. Our group as well as others have histologically proven that INS can safely and reliably excite nerves without inflicting damage. Given these advantages over traditional means of ES, the investigators believe INS is a viable alternative stimulation technique especially in surgical cases where there is a need for confined neurostimulation. The goal of this proposal is to take advantage of INS' intrinsic strengths and apply them to upper limb surgeries where spatially precise neurostimulation is necessary for nerve identification and localization. This study will build upon our group's previous clinical work and further establish INS as a valuable addition to clinical neurostimulation methods.
The objective of this proposal is two-fold: to demonstrate the efficacy of INS for spatially selective nerve stimulation in the upper extremity and to determine the histological safety of INS using diode laser systems in human patients. To do so, the investigators will recruit patients undergoing brachial plexus reconstruction (BPR) and nerve transfer surgeries wherein both the effectiveness and spatial selectivity of INS can be demonstrated and histological samples can be obtained without detriment to the patients' quality of care or recovery. To accomplish these objectives, the investigators propose the following aims:
Aim 1: Design and fabricate a clinical fiberoptic probe for a diode-based INS system Using our existing diode lasers, the investigators will create a clinical diode laser INS system by constructing INS fiberoptic probes. Fiberoptic probes will be designed and characterized to collect light from our diode lasers and deliver that light to the nerve. The probes will be sterilizable, ergonomic and maneuverable, transmissive at the relevant wavelengths, and provide consistent stimulation parameters. The probe design will be based on existing clinical ES probes and modified based on surgeon feedback.
Aim 2: Demonstrate the efficacy of INS in nerve transfer cases While INS with expensive clinical lasers has been shown to be an effective means of nerve stimulation, INS with diode lasers has yet to be demonstrated in human patients. Here, the investigator will stimulate nerves identified for transfer or grafting over a range of simulation parameters (pulse width, spot size, energy per unit area, etc) to determine the stimulation threshold. Only portions of the nerve that are no longer functionally required will be stimulated optically. Successful INS events will be determined by visual muscle contractions. Stimulation thresholds will be determined by fitting the data to a cumulative distribution function.
Aim 3: Determine the histological safety of the diode-based INS system In conjunction with Aim 2, stimulation sites on the nerve will be harvested and histologically examined for evidence of INS-induced damage. Stimulation sites will be marked with a tissue dye and excised for histological preparation. Regarding the tissue dye, the study surgeon will use a sterile surgical marking pen to mark the stimulation site. These sterile surgical marking pens are meant to be used in-vivo to mark tissue. The sterile surgical marking pens are used regularly in routine care to mark tissue intraoperatively. There is no additional risk to study participants who will have their stimulation site marked with a sterile surgical marking pen. The stimulation site (nerve segment) that will be marked with the sterile surgical marking pen will be excised for histological preparation.
Once the samples are fixed and sliced, they will be stained with toluidine blue and/or Luxol fast blue-Periodic acid Schiff stains and imaged. Imaged slides will be examined for evidence of myelin disruption, collagen hyalinization, and charring among other criteria. A histological damage grading scheme will also be developed based on the severity and depth of the damage with respect to the nerve itself. Damage thresholds will similarly be determined using Probit Analysis and compared to the stimulation threshold to determine the margin of safety.
INS has the potential to serve as valuable neural stimulation technique in the clinic. Due to its high degree of spatial selectivity, INS could improve upon current electrical methods of stimulation that can excite multiple nerves or fascicles at once due to current spread and therefore reduce uncertainty during nerve identification procedures. While INS has been successfully and safely utilized in humans, cost-effective laser diode systems have yet to be evaluated. This proposal will allow for the development and testing of a clinical diode-based INS system in terms of both efficacy and safety. This proposal brings together a complementary team of investigators with unique expertise in both the clinical and technical aspects of INS and its applications. The utilization of INS in BPR and nerve transfer cases will allow us to determine the stimulation and safety thresholds of diode-based INS in humans will pave the way for this technique to be employed in other procedures where improved spatial specificity is highly advantageous. By extending the use of INS to upper limb cases, this technique could significantly impact the standard of care in surgeries utilizing stimulation to identify specific nerves and nerve fascicles.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Brachial plexus and/or nerve transfer surgery patients | – | Procedure: Infrared Neural StimulationPatients set to undergo brachial plexus reconstruction or nerve transfer surgery that are 18 years or older. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients will be identified through VUMC Orthopaedic outpatient clinics and consultations.
Key inclusion criteria (2 listed)
- Patient set to undergo a brachial plexus reconstruction or nerve transfer surgery
- 18 years or older
Key exclusion criteria (5 listed)
- Patients under the age of 18
- Patients who are unwilling to take part in study
- Patients who have documented psychiatric disorder that limits ability to consent
- Patients who do not speak English
- Patients who are pregnant
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Infrared Neural StimulationWe will stimulate nerves identified for transfer or grafting over a range of simulation parameters (pulse width, spot size, energy per unit area, etc) to determine the stimulation threshold. Only portions of the nerve that are no longer functionally required will be stimulated optically. Successful INS events will be determined by visual muscle contractions. Stimulation thresholds will be determined by fitting the data to a cumulative distribution function. Stimulation sites on the nerve will be harvested and histologically examined for evidence of INS-induced damage. | Procedure or surgery | Brachial plexus and/or nerve transfer surgery patients |
Primary outcome
Stimulation threshold
Time frame: Day of surgery
The stimulation threshold (H100) will be defined as the radiant exposure at which 100% of the laser pulses evoked CMAP responses and will be used to compare all data. To determine the stimulation threshold, recordings from each trial will be analyzed to determine the number of INS-evoked CMAPs. The number of evoked CMAPs will be divided by the total number of delivered pulses to determine the activation probability for every radiant exposure.
Transition rate
Time frame: Day of surgery
The transition rate to 100% activation probability will be defined as the peak slope of the fitted CDF (mpeak). This represents how well-defined the stimulation threshold is. For instance, a more immediate transition from 0 to 100%, a greater mpeak, corresponds to every pulse going from 0% to 100% activation over a small range of radiant exposures. Practically, a sharper transition rate translates to more reliable and predictable stimulation. Changes in peak CDF slope will then be compared across conditional groups.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2025.
- Background: PubMed 24791754Antoniadis G, Kretschmer T, Pedro MT, Konig RW, Heinen CP, Richter HP. Iatrogenic nerve injuries: prevalence, diagnosis and treatment. Dtsch Arztebl Int. 2014 Apr 18;111(16):273-9. doi: 10.3238/arztebl.2014.0273.
- Background: PubMed 15252097Teboul F, Kakkar R, Ameur N, Beaulieu JY, Oberlin C. Transfer of fascicles from the ulnar nerve to the nerve to the biceps in the treatment of upper brachial plexus palsy. J Bone Joint Surg Am. 2004 Jul;86(7):1485-90. doi: 10.2106/00004623-200407000-00018.
- Background: PubMed 8201186Oberlin C, Beal D, Leechavengvongs S, Salon A, Dauge MC, Sarcy JJ. Nerve transfer to biceps muscle using a part of ulnar nerve for C5-C6 avulsion of the brachial plexus: anatomical study and report of four cases. J Hand Surg Am. 1994 Mar;19(2):232-7. doi: 10.1016/0363-5023(94)90011-6.
- Background: PubMed 9708387Leechavengvongs S, Witoonchart K, Uerpairojkit C, Thuvasethakul P, Ketmalasiri W. Nerve transfer to biceps muscle using a part of the ulnar nerve in brachial plexus injury (upper arm type): a report of 32 cases. J Hand Surg Am. 1998 Jul;23(4):711-6. doi: 10.1016/S0363-5023(98)80059-2.
- Background: PubMed 1928872Popovic D, Gordon T, Rafuse VF, Prochazka A. Properties of implanted electrodes for functional electrical stimulation. Ann Biomed Eng. 1991;19(3):303-16. doi: 10.1007/BF02584305.
- Background: PubMed 9919824Liang DH, Lusted HS, White RL. The nerve-electrode interface of the cochlear implant: current spread. IEEE Trans Biomed Eng. 1999 Jan;46(1):35-43. doi: 10.1109/10.736751.
- Background: PubMed 15825879Testerman RL. Comments on "accuracy limitations of chronaxie values". IEEE Trans Biomed Eng. 2005 Apr;52(4):750. doi: 10.1109/tbme.2004.836506.
- Background: PubMed 17537515Wells J, Konrad P, Kao C, Jansen ED, Mahadevan-Jansen A. Pulsed laser versus electrical energy for peripheral nerve stimulation. J Neurosci Methods. 2007 Jul 30;163(2):326-37. doi: 10.1016/j.jneumeth.2007.03.016. Epub 2007 Mar 31.
- Background: PubMed 26157986Cayce JM, Wells JD, Malphrus JD, Kao C, Thomsen S, Tulipan NB, Konrad PE, Jansen ED, Mahadevan-Jansen A. Infrared neural stimulation of human spinal nerve roots in vivo. Neurophotonics. 2015 Jan;2(1):015007. doi: 10.1117/1.NPh.2.1.015007. Epub 2015 Feb 23.
- Background: PubMed 23994125Cayce JM, Friedman RM, Chen G, Jansen ED, Mahadevan-Jansen A, Roe AW. Infrared neural stimulation of primary visual cortex in non-human primates. Neuroimage. 2014 Jan 1;84:181-90. doi: 10.1016/j.neuroimage.2013.08.040. Epub 2013 Aug 28.
- Background: PubMed 18209145Morris LG, Ziff DJ, DeLacure MD. Malpractice litigation after surgical injury of the spinal accessory nerve: an evidence-based analysis. Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):102-7. doi: 10.1001/archotol.134.1.102.
- Background: PubMed 20709343Abadin SS, Kaplan EL, Angelos P. Malpractice litigation after thyroid surgery: the role of recurrent laryngeal nerve injuries, 1989-2009. Surgery. 2010 Oct;148(4):718-22; discussion 722-3. doi: 10.1016/j.surg.2010.07.019. Epub 2010 Aug 14.
- Individual participant dataSharing planned: No. There is no plan to make individual participant data available to other researchers.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Infrared Neural Stimulation (INS), run by Vanderbilt University Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 1 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stimulation threshold (time frame: Day of surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04601337, which also lists 33 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2025.